This website is intended for healthcare professionals only

Trending Topic

Macro shot of eye featuring holographic HUD graphics layered over pupil and cornea, neon light accents and sharp reflections, high tech cyber vision theme, ultra detailed 8k
7 mins

Trending Topic

Developed by Touch
Mark CompleteCompleted
BookmarkBookmarked

Corneal ectatic disorders, such as keratoconus, progressively weaken corneal integrity, leading to thinning, irregular astigmatism and visual deterioration.1 Typically progressive in nature, these ectasias result in increasingly thinner corneas, causing the cornea to protrude forward into a cone shape. This leads to increasing amounts of myopia and astigmatism – both regular and irregular – as the disease […]

Bennie Jeng, WOC 2018 – Developing our Understanding of Dry Eye Disease

Share
Facebook
X (formerly Twitter)
LinkedIn
Via Email
Mark CompleteCompleted
BookmarkBookmarked
Copy LinkLink Copied
Published Online: Jul 19th 2018

We met up with Editorial Board member Bennie Jeng, who updated us on the exciting recent developments in dry eye disease and several new therapies are in development in the US. Dr Jeng talked about his experience with scleral contact lenses, which have proved particularly useful for very severe dry eye patients with GVHD and Stevens-Johnson disease in his clinic. There is still unmet need for patients with chronic severe dry eye disease patients, including access to scleral contact lenses and also recognising and understanding neuropathic pain. A better understanding of the mechanisms behind dry eye disease will help to develop new treatments.

Questions:
1. What have been the most significant recent developments in the area of dry eye disease? (0:29)
2. Discuss the current unmet needs and/or the challenges you face when treating patients with dry eye disease. (1:53)
3. What developments are you most excited about in the area of dry eye disease over the next few years? (3:10)
4. Which presentations/data have interested you the most at this year’s WOC? (3:58)

Share
Facebook
X (formerly Twitter)
LinkedIn
Via Email
Mark CompleteCompleted
BookmarkBookmarked
Copy LinkLink Copied
Close Popup